BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23456789)

  • 1. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
    Sharma A; Schwartz SM; Méndez E
    Cancer; 2013 May; 119(10):1845-52. PubMed ID: 23456789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Sharma AK; Lentsch EJ; Day TA
    Cancer; 2017 Jul; 123(14):2651-2660. PubMed ID: 28241092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.
    Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA
    Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
    Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
    Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
    Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
    Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
    Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
    Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
    Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
    Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
    Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
    Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
    Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
    Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
    Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis.
    VanderWalde NA; Meyer AM; Liu H; Tyree SD; Zullig LL; Carpenter WR; Shores CD; Weissler MC; Hayes DN; Fleming M; Chera BS
    J Geriatr Oncol; 2013 Jul; 4(3):262-70. PubMed ID: 24058388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.